Corcept Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Aug 24 | SellUS$110,737 | Gary Robb | Individual | 3,101 | US$35.71 | |
06 Dec 23 | SellUS$37,301 | Gary Robb | Individual | 1,381 | US$27.01 |
Insider Trading Volume
Insider Buying: CORT insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 43,782 | 0.0418% |
General Public | 2,874,407 | 2.74% |
Hedge Funds | 6,509,002 | 6.21% |
Individual Insiders | 12,155,982 | 11.6% |
Institutions | 83,191,964 | 79.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
16,539,159 | US$927.7m | 0% | 0.01% | |||
10,006,330 | US$561.3m | 4.74% | 0.01% | |||
8,266,756 | US$463.7m | 0.35% | 15.75% | |||
6,509,002 | US$365.1m | -5.84% | 0.49% | |||
5,310,196 | US$297.8m | 0% | no data | |||
3,813,724 | US$213.9m | -0.05% | 4.55% | |||
3,519,263 | US$197.4m | 0.57% | 0.01% | |||
3,022,335 | US$169.5m | 6.72% | no data | |||
2,532,499 | US$142.0m | -5.37% | 0.02% | |||
2,411,362 | US$135.3m | 0% | 0.09% | |||
2,378,758 | US$133.4m | 4.36% | 0.01% | |||
2,215,093 | US$124.2m | 0% | no data | |||
1,580,621 | US$88.7m | 6.55% | 0.06% | |||
1,513,975 | US$84.9m | -4.41% | 0.53% | |||
1,363,342 | US$76.5m | 24.6% | no data | |||
1,318,137 | US$73.9m | -13.4% | 0.06% | |||
1,314,373 | US$73.7m | 0% | no data | |||
1,223,781 | US$68.6m | 40.5% | 0.23% | |||
1,026,487 | US$57.6m | 5.47% | 0.01% | |||
925,584 | US$51.9m | 14.5% | 0.01% | |||
921,387 | US$51.7m | -1.16% | 0.01% | |||
859,563 | US$48.2m | 20% | 0.2% | |||
822,123 | US$46.1m | 0% | no data | |||
788,064 | US$44.2m | -17% | 0.06% | |||
672,389 | US$37.7m | 25.2% | 0.01% |